Hemogenyx Pharmaceuticals Plc Stock Price Prediction
| HOPHF Stock | USD 0 0.00 0.00% |
Oversold Vs Overbought
0
Oversold | Overbought |
Using Hemogenyx Pharmaceuticals hype-based prediction, you can estimate the value of Hemogenyx Pharmaceuticals Plc from the perspective of Hemogenyx Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Hemogenyx Pharmaceuticals to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Hemogenyx because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Hemogenyx Pharmaceuticals after-hype prediction price | USD 0.0031 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Hemogenyx |
Hemogenyx Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Hemogenyx Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Hemogenyx Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Hemogenyx Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Hemogenyx Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Hemogenyx Pharmaceuticals' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Hemogenyx Pharmaceuticals' historical news coverage. Hemogenyx Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.00 and 0.00, respectively. We have considered Hemogenyx Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Hemogenyx Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Hemogenyx Pharmaceuticals is based on 3 months time horizon.
Hemogenyx Pharmaceuticals Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Hemogenyx Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Hemogenyx Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Hemogenyx Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0 | 0 | 0.00 |
|
Hemogenyx Pharmaceuticals Hype Timeline
Hemogenyx Pharmaceuticals is currently traded for 0. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Hemogenyx is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Hemogenyx Pharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 0.00. About 13.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.78. Some equities with similar Price to Book (P/B) outperform the market in the long run. Hemogenyx Pharmaceuticals recorded a loss per share of 0.01. The entity had not issued any dividends in recent years. Assuming the 90 days horizon the next forecasted press release will be in a few days. Check out Hemogenyx Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Hemogenyx Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Hemogenyx Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Hemogenyx Pharmaceuticals' future price movements. Getting to know how Hemogenyx Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Hemogenyx Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| HESG | Health Sciences Gr | 0.00 | 1 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MMIRF | MedMira | 0.00 | 0 per month | 0.00 | 0.12 | 0.00 | (0.17) | 321.49 |
Hemogenyx Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Hemogenyx price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Hemogenyx using various technical indicators. When you analyze Hemogenyx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Hemogenyx Pharmaceuticals Predictive Indicators
The successful prediction of Hemogenyx Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Hemogenyx Pharmaceuticals Plc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Hemogenyx Pharmaceuticals based on analysis of Hemogenyx Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Hemogenyx Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Hemogenyx Pharmaceuticals's related companies.
Story Coverage note for Hemogenyx Pharmaceuticals
The number of cover stories for Hemogenyx Pharmaceuticals depends on current market conditions and Hemogenyx Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Hemogenyx Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Hemogenyx Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Hemogenyx Pharmaceuticals Short Properties
Hemogenyx Pharmaceuticals' future price predictability will typically decrease when Hemogenyx Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Hemogenyx Pharmaceuticals Plc often depends not only on the future outlook of the potential Hemogenyx Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Hemogenyx Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 979.7 M |
Complementary Tools for Hemogenyx Pink Sheet analysis
When running Hemogenyx Pharmaceuticals' price analysis, check to measure Hemogenyx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemogenyx Pharmaceuticals is operating at the current time. Most of Hemogenyx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hemogenyx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemogenyx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hemogenyx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |